Open AccessCommentary: Anti-vascular endothelial growth factor therapies in vitreo-retina practice: Biosimilars versus biologics
Author(s) -
Giridhar Anantharaman
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_40_21
Subject(s) - ranibizumab , biosimilar , medicine , aflibercept , macular degeneration , context (archaeology) , bevacizumab , pegaptanib , pharmacology , vascular endothelial growth factor , intensive care medicine , ophthalmology , vegf receptors , paleontology , chemotherapy , biology